Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-081611
Filing Date
2025-06-04
Accepted
2025-06-04 16:05:10
Documents
1
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4167
  Complete submission text file 0000950170-25-081611.txt   5593
Mailing Address
Business Address
WIINBERG ULF (Reporting) CIK: 0001187314 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40908 | Film No.: 251023101

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Issuer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)